Skip to main content

Want a detailed portfolio tracker?

Applied Dna Sciences (APDN) Total Debt (2005 - 2025)

Applied Dna Sciences (APDN) total debt from Jun 30, 2005 to Jun 30, 2025. The current Applied Dna Sciences (APDN) total debt is $2.95M. You can adjust inflation or export chart.

Total Debt

Total Debt

Applied Dna Sciences (APDN) Total Debt CAGR table

PeriodCAGR
1 Year TTM-54.18%
3 Years TTM-9.72%
5 Years TTM-5.58%
10 Years TTM+2.68%
All Time TTM-4.49%

Annual Total Debt change of Applied Dna Sciences (APDN)

YearTotal DebtChange
2024$3.82M
-56.49%
2023$8.78M
-6.20%
2022$9.36M
+183.64%
2021$3.30M
-41.39%
2020$5.63M
+27.66%
2019$4.41M
-9.63%
2018$4.88M
+275.38%
2017$1.30M
-75.00%
2016$5.20M
+73.91%
2015$2.99M
-39.84%
2014$4.97M
+32.18%
2013$3.76M
+537.29%
2012$590K
-86.89%
2011$4.50M
+49.50%
2010$3.01M
-7.38%
2009$3.25M
-79.53%
2008$16M
+10.58%
2007$14M
+0.70%
2006$14M
+448.46%
2005$2.60M
N/A

Comparison Applied Dna Sciences (APDN) total debt with competitors

Applied Dna Sciences (APDN) total debt is $2.95M.

TickerNameTotal DebtUpside
ADVBAdvanced Biomed Inc$1.44M-51.30%
NDRAENDRA Life Sciences Inc$1.65M-44.02%
MBAICheckCap Ltd$1.83M-38.07%
CHEKCheck-Cap Ltd$1.83M-38.07%
MYNZMainz Biomed N.V.$3.13M+6.06%
BIAFBioAffinity Technologies Inc$4.28M+45.22%
ISPCiSpecimen Inc$6.44M+118.41%
PRPOPrecipio Inc$6.64M+124.95%
XWELXWELL Inc$14.91M+405.56%
XGNExagen Inc$37.52M+1172.03%
IMDXInsight Molecular Diagnostics Inc$51.12M+1632.81%
FONRFonar Corp$54.77M+1756.47%
PRPHProPhase Labs Inc$58.84M+1894.61%
PSNLPersonalis Inc$70.63M+2294.24%
BDSXBiodesix Inc$85.50M+2798.47%
CSTLCastle Biosciences Inc$86.39M+2828.44%
VCYTVeracyte Inc$91.99M+3018.44%
CDNACaredx Inc$97.53M+3206.00%
FLGTFulgent Genetics Inc$112.22M+3703.90%
MDXHMDxHealth SA$160.05M+5325.32%
BLLNBilliontoone Inc - Class A$195.11M+6513.80%
TWSTTwist Bioscience Corp$221.12M+7395.59%
WGSGeneDx Holdings Corp - Class A$252.18M+8448.37%
ADPTAdaptive Biotechnologies Corp$281.70M+9449.22%
GRALGRAIL Inc$302.79M+10164.00%
BNRBurning Rock Biotech Ltd$304.48M+10221.29%
MYGNMyriad Genetics Inc$336.30M+11300.00%
NEONeogenomics Inc$523.27M+17637.90%
NOTVInotiv, Inc. Common Stock$625.32M+21097.25%
OPKOpko Health Inc$652.19M+22008.00%
NTRANatera Inc$840.38M+28387.46%
MEDPMedpace Holdings Inc$1.53B+51808.44%
IDXXIdexx Laboratories Inc$1.83B+61913.36%
GHGuardant Health Inc$2.10B+70963.19%
RDNTRadnet Inc$2.53B+85753.46%
SHCSotera Health Company$2.61B+88489.59%
EXASExact Sciences Corp$3.46B+117173.80%
MTDMettler-Toledo International Inc$3.71B+125689.76%
CRLCharles River Laboratories International Inc$4.74B+160645.59%
RVTYRevvity Inc$4.81B+163081.39%
AAgilent Technologies Inc$5.94B+201357.63%
ICLRIcon Plc$7.08B+239777.90%
WATWaters Corp$9.24B+313086.44%
LHLaboratory Corp Of America Holdings$10.34B+350462.71%
IQVIQVIA Holdings Inc$23.33B+790611.86%